Search Results

There are 12667 results for: content related to: Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer

  1. You have free access to this content
    Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas

    Cancer

    Volume 119, Issue 2, 15 January 2013, Pages: 356–362, Melissa L. Johnson, Camelia S. Sima, Jamie Chaft, Paul K. Paik, William Pao, Mark G. Kris, Marc Ladanyi and Gregory J. Riely

    Version of Record online : 18 JUL 2012, DOI: 10.1002/cncr.27730

  2. You have full text access to this OnlineOpen article
    Clinical outcome of epidermal growth factor receptor-tyrosine kinase inhibitors therapy for patients with overlapping kirsten rat sarcoma 2 viral oncogene homolog and epidermal growth factor receptor gene mutations

    Thoracic Cancer

    Volume 7, Issue 1, January 2016, Pages: 24–31, Hong Zhang, Hua Bai, Xiaodan Yang, Jia Zhong, Tongtong An, Jun Zhao and Jie Wang

    Version of Record online : 11 JUN 2015, DOI: 10.1111/1759-7714.12266

  3. You have free access to this content
    Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer

    International Journal of Cancer

    Volume 130, Issue 8, 15 April 2012, Pages: 1733–1744, Noriaki Sunaga, Hisao Imai, Kimihiro Shimizu, David S. Shames, Seiichi Kakegawa, Luc Girard, Mitsuo Sato, Kyoichi Kaira, Tamotsu Ishizuka, Adi F. Gazdar, John D. Minna and Masatomo Mori

    Version of Record online : 3 AUG 2011, DOI: 10.1002/ijc.26164

  4. You have free access to this content
    Reversed mutation rates of KRAS and EGFR genes in adenocarcinoma of the lung in Taiwan and their implications

    Cancer

    Volume 113, Issue 11, 1 December 2008, Pages: 3199–3208, Chun-Chieh Wu, Hui-Yu Hsu, Hui-Ping Liu, John Wen-Cheng Chang, Ya-Ting Chen, Wen-Yu Hsieh, Jia-Juan Hsieh, Meng-Shu Hsieh, Yi-Rong Chen and Shiu-Feng Huang

    Version of Record online : 17 OCT 2008, DOI: 10.1002/cncr.23925

  5. Comparison of Targeted Next-Generation Sequencing (NGS) and Real-Time PCR in the Detection of EGFR, KRAS, and BRAF Mutations on Formalin-Fixed, Paraffin-Embedded Tumor Material of Non-Small Cell Lung Carcinoma—Superiority of NGS

    Genes, Chromosomes and Cancer

    Volume 52, Issue 5, May 2013, Pages: 503–511, Katja Tuononen, Satu Mäki-Nevala, Virinder Kaur Sarhadi, Aino Wirtanen, Mikko Rönty, Kaisa Salmenkivi, Jenny M. Andrews, Aino I. Telaranta-Keerie, Sari Hannula, Sonja Lagström, Pekka Ellonen, Aija Knuuttila and Sakari Knuutila

    Version of Record online : 30 JAN 2013, DOI: 10.1002/gcc.22047

  6. Routine EGFR and KRAS Mutation analysis using COLD-PCR in non-small cell lung cancer

    International Journal of Clinical Practice

    Volume 66, Issue 8, August 2012, Pages: 748–752, A. Pennycuick, T. Simpson, D. Crawley, R. Lal, G. Santis, P. Cane, K. Tobal and J. Spicer

    Version of Record online : 16 JUL 2012, DOI: 10.1111/j.1742-1241.2012.02961.x

  7. You have free access to this content
    Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma

    Cancer

    Volume 109, Issue 8, 15 April 2007, Pages: 1561–1569, Jeeyun Lee, Kee-Taek Jang, Chang-Seok Ki, Taekyu Lim, Young Suk Park, Ho Yeong Lim, Dong-Wook Choi, Won Ki Kang, Keunchil Park and Joon Oh Park

    Version of Record online : 12 MAR 2007, DOI: 10.1002/cncr.22559

  8. You have free access to this content
    Pemetrexed versus erlotinib in pretreated patients with advanced non–small cell lung cancer: A Hellenic Oncology Research Group (HORG) randomized phase 3 study

    Cancer

    Volume 119, Issue 15, 1 August 2013, Pages: 2754–2764, Athanasios Karampeazis, Alexandra Voutsina, John Souglakos, Nikos Kentepozidis, Stelios Giassas, Charalambos Christofillakis, Athanasios Kotsakis, Pavlos Papakotoulas, Ageliki Rapti, Maria Agelidou, Sofia Agelaki, Lambros Vamvakas, George Samonis, Dimitris Mavroudis and Vassilis Georgoulias

    Version of Record online : 9 MAY 2013, DOI: 10.1002/cncr.28132

  9. You have full text access to this OnlineOpen article
    Assessment of EGFR and KRAS mutation status from FNAs and core-needle biopsies of non-small cell lung cancer

    Cancer Cytopathology

    Volume 123, Issue 4, April 2015, Pages: 230–236, Maria D. Lozano, Tania Labiano, Jose Echeveste, Alfonso Gurpide, Salvador Martín-Algarra, Guili Zhang, Abha Sharma and John F. Palma

    Version of Record online : 19 DEC 2014, DOI: 10.1002/cncy.21513

  10. Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas

    The Journal of Pathology

    Volume 212, Issue 3, July 2007, Pages: 287–294, H Sakamoto, J Shimizu, Y Horio, R Ueda, T Takahashi, T Mitsudomi and Y Yatabe

    Version of Record online : 29 MAY 2007, DOI: 10.1002/path.2165

  11. EGFR gene copy number predicts response to anti-EGFR treatment in RAS wild type and RAS/BRAF/PIK3CA wild type metastatic colorectal cancer

    International Journal of Cancer

    Volume 140, Issue 4, 15 February 2017, Pages: 922–929, Annika Ålgars, Jari Sundström, Minnamaija Lintunen, Terhi Jokilehto, Soili Kytölä, Milja Kaare, Reetta Vainionpää, Arto Orpana, Pia Österlund, Ari Ristimäki, Olli Carpen and Raija Ristamäki

    Version of Record online : 23 NOV 2016, DOI: 10.1002/ijc.30507

  12. You have free access to this content
    Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma

    Cancer Cytopathology

    Volume 121, Issue 9, September 2013, Pages: 500–507, Guoping Cai, Rebecca Wong, David Chhieng, Gillian H. Levy, Scott N. Gettinger, Roy S. Herbst, Jonathan T. Puchalski, Robert J. Homer and Pei Hui

    Version of Record online : 12 MAR 2013, DOI: 10.1002/cncy.21288

  13. You have free access to this content
    Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas

    Cancer

    Volume 118, Issue 23, 1 December 2012, Pages: 5840–5847, Paul K. Paik, Melissa L. Johnson, Sandra P. D'Angelo, Camelia S. Sima, Daphne Ang, Snjezana Dogan, Vincent A. Miller, Marc Ladanyi, Mark G. Kris and Gregory J. Riely

    Version of Record online : 17 MAY 2012, DOI: 10.1002/cncr.27637

  14. You have free access to this content
    Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement

    Cancer

    Volume 118, Issue 3, 1 February 2012, Pages: 729–739, Hye Ryun Kim, Hyo Sup Shim, Jin-Haeng Chung, Young Joo Lee, Yun Kyoung Hong, Sun Young Rha, Se Hoon Kim, Sang-Jun Ha, Se Kyu Kim, Kyung Young Chung, Ross Soo, Joo Hang Kim and Byoung Chul Cho

    Version of Record online : 30 JUN 2011, DOI: 10.1002/cncr.26311

  15. You have free access to this content
    Clinicopathological features of lung adenocarcinoma with KRAS mutations

    Cancer

    Volume 117, Issue 18, 15 September 2011, Pages: 4257–4266, Seiichi Kakegawa, Kimihiro Shimizu, Masayuki Sugano, Yohei Miyamae, Kyoichi Kaira, Takuya Araki, Tetsuhiro Nakano, Mitsuhiro Kamiyoshihara, Osamu Kawashima and Izumi Takeyoshi

    Version of Record online : 8 MAR 2011, DOI: 10.1002/cncr.26010

  16. Mitochondrial DNA mutations in respiratory complex-I in never-smoker lung cancer patients contribute to lung cancer progression and associated with EGFR gene mutation

    Journal of Cellular Physiology

    Volume 227, Issue 6, June 2012, Pages: 2451–2460, Santanu Dasgupta, Ethan Soudry, Nitai Mukhopadhyay, Chunbo Shao, John Yee, Stephan Lam, Wan Lam, Wei Zhang, Adi F Gazdar, Paul B Fisher and David Sidransky

    Version of Record online : 24 FEB 2012, DOI: 10.1002/jcp.22980

  17. You have free access to this content
    Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer

    Cancer

    Volume 118, Issue 18, 15 September 2012, Pages: 4502–4511, Robert C. Doebele, Xian Lu, Christopher Sumey, DeLee A. Maxson, Andrew J. Weickhardt, Ana B. Oton, Paul A. Bunn Jr, Anna E. Barón, Wilbur A. Franklin, Dara L. Aisner, Marileila Varella-Garcia and D. Ross Camidge

    Version of Record online : 26 JAN 2012, DOI: 10.1002/cncr.27409

  18. You have full text access to this Open Access content
    Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis

    Journal of Cellular and Molecular Medicine

    Volume 14, Issue 1-2, January-February 2010, Pages: 51–69, Luis Paz-Ares, Denis Soulières, Ivan Melezínek, Joachim Moecks, Lorenz Keil, Tony Mok, Rafael Rosell and Barbara Klughammer

    Version of Record online : 8 DEC 2009, DOI: 10.1111/j.1582-4934.2009.00991.x

  19. You have full text access to this OnlineOpen article
    EGFR, KRAS, BRAF, and HER-2 molecular status in brain metastases from 77 NSCLC patients

    Cancer Medicine

    Volume 2, Issue 3, June 2013, Pages: 296–304, Claire Villalva, Valérie Duranton-Tanneur, Karline Guilloteau, Fanny Burel-Vandenbos, Michel Wager, Jérôme Doyen, Pierre Marie Levillain, Denys Fontaine, Hélène Blons, Florence Pedeutour and Lucie Karayan-Tapon

    Version of Record online : 23 APR 2013, DOI: 10.1002/cam4.82

  20. You have full text access to this Open Access content
    Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer

    Cancer Science

    Volume 98, Issue 12, December 2007, Pages: 1817–1824, Tetsuya Mitsudomi and Yasushi Yatabe

    Version of Record online : 20 SEP 2007, DOI: 10.1111/j.1349-7006.2007.00607.x